Masoud Heshmati

Hello, I'm Masoud Heshmati, a 32-year-old immunologist whose journey into the captivating world of biomedical sciences unfolded during undergraduate studies in Cellular and Molecular Biology. Passionate about understanding the complexities of cancer, my interest crystallized during my master's research on Cancer Immunology. Engaging in spirited conversations about the manipulation of cellular mechanisms and signaling pathways in immune cells, I faced a profound shift when my brother was diagnosed with cancer. This personal encounter intensified my commitment to the field. I contributed to various research projects and explored connections between hormones like ghrelin and cancer-related pathways. My experiences, ranging from statistical analyses to molecular biology techniques, propel me toward emerging as a top-tier scientist dedicated to advancing the understanding and treatment of cancer.

Living in : Iran

Gender : MaleRace : No Response

0Followers 0Following

Academic Profile

Posts

Contact Information

-Email

MasoudHeshmati2ApplyChance Link

Educations

ImmunologyMaster'sShahrekord University of Medical Sciences2019-08-30 Iran

Biochemistry, Cellular and Molecular BiologyBachelor'sIslamic Azad University Mashhad2015-06-17 Iran

Work Experiences

Lab Technician

at MUMS

I am currently working in this role

Lab Technician

at Shariati Hospital

Start : 30-Apr-2021

End : 31-Mar-2022

English Scores

IELTS31-Aug-2023

6/9Total

Reading :

5.5/9

Speaking :

6/9

Listening :

6/9

Writing :

6/9

Journal Publications

Publication Title :

Ghrelin induces autophagy and CXCR4 expression via the SIRT1/AMPK axis in lymphoblastic leukemia cell linesFirst author

Journal :

Cellular Signalling

Link :

View Link

Publication Title :

Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cellsFirst author

Journal :

Molecular Biology Reports

Link :

View Link

Publication Title :

Comparing the frequency of CD33+ pSTAT3+ myeloid-derived suppressor cells and IL-17+ lymphocytes in patients with prostate cancer and benign prostatic hyperplasiaFirst author

Journal :

Cell Biology International

Link :

View Link

Publication Title :

The relation between the ghrelin receptor and FOXP3 in bladder cancerFirst author

Journal :

Biotechnic and Histochemistry

Link :

View Link

Publication Title :

Immune checkpoints in targeted- immunotherapy of pancreatic cancer: new hope for clinical developmentFirst author